Keyphrases
Cannabidiol
100%
Non-psychoactive Cannabinoids
100%
Encephalitogenic T Cells
100%
CB2 Receptor
40%
MOG35-55
40%
Autoimmune Disease
20%
Inflammatory Diseases
20%
Neuroinflammation
20%
Molecular Modeling
20%
Cannabinoid Receptor 2
20%
Cannabinoid Receptor 1 (CB1R)
20%
Interleukin-17 (IL-17)
20%
Multiple Sclerosis
20%
Anti-inflammatory Effect
20%
Synthetic Derivatives
20%
Experimental Autoimmune Encephalomyelitis
20%
CB1 Receptor
20%
Autoimmune
20%
Binding Assay
20%
Nanomolar Concentrations
20%
Receptor-independent
20%
Myelin Oligodendrocyte Glycoprotein
20%
Induced Proliferation
20%
Synthetic Cannabidiol
20%
Autoreactive
20%
Anti-inflammatory Potential
20%
Peripheral Inflammation
20%
Experimental Autoimmune Encephalomyelitis/multiple Sclerosis
20%
Immunology and Microbiology
T Cell
100%
Multiple Sclerosis
100%
Experimental Autoimmune Encephalomyelitis
100%
Autoimmune Disease
50%
Cytokine
50%
Antiinflammatory Activity
50%
Myelin Oligodendrocyte Glycoprotein
50%
Molecular Model
50%
Interleukin 17
50%
Neuroscience
T Cell
100%
Cannabidiol
100%
Cannabinoid
100%
Cannabinoid 2 Receptor
50%
Anti-Inflammatory
33%
Multiple Sclerosis
33%
Experimental Autoimmune Encephalomyelitis
33%
Cannabinoid 1 Receptor
33%
Interleukin 17
16%
Molecular Model
16%
Myelin Oligodendrocyte Glycoprotein
16%
Autoimmune Disease
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabidiol
100%
Cannabinoid
100%
Cannabinoid 2 Receptor
50%
Cannabinoid 1 Receptor
33%
Experimental Autoimmune Encephalomyelitis
33%
Multiple Sclerosis
33%
Anti-Inflammatory Drug
16%
Inflammation
16%
Autoimmune Disease
16%
Cytokine
16%
Nervous System Inflammation
16%
Antiinflammatory Activity
16%
Inflammatory Disease
16%
Interleukin 17
16%
Myelin Oligodendrocyte Glycoprotein
16%